Article Text

other Versions

PDF
Serum proteomic profiling of obese patients: correlation with pathology and evolution after bariatric surgery
  1. Viviane Trak-Smayra (tsmayra{at}cyberia.net.lb)
  1. CNRS UMR 8149 Faculté des Sciences pharmaceutiques, Paris, France
    1. Delphine Dargere (dargere{at}pharmacie.univ-paris5.fr)
    1. CNRS UMR 8149 Faculté des Sciences pharmaceutiques, Paris, France
      1. Roger Noun (noun{at}cyberia.net.lb)
      1. Service de Chirurgie hépato-biliaire, Hôtel-Dieu de France, Beyrouth, Lebanon
        1. Miguel Albuquerque (miguel.albuquerque{at}bjn.aphp.fr)
        1. CNRS UMR 8149 Faculté des Sciences pharmaceutiques, Paris, France
          1. César Yaghi (yaghi{at}cyberia.net.lb)
          1. Service d'Hépatologie Hôtel-Dieu de France, Beyrouth, Lebanon
            1. Marie-Héléne Gannagé-Yared (gannage-yared{at}cyberia.net.lb)
            1. Service de Biochimie Hôtel-Dieu de France, Beyrouth, Lebanon
              1. Pierre Bedossa (pbedossa{at}teaser.fr)
              1. CNRS UMR 8149 Faculté des Sciences pharmaceutiques, Paris, France
                1. Valerie Paradis (vparadis{at}teaser.fr)
                1. Beaujon hospital, France

                  Abstract

                  Objective Chronic liver diseases, including cirrhosis, may develop in obese patients. Steatosis and non-alcoholic steatohepatitis (NASH) are risk factors for progression to fibrosis. To date, diagnosis of steatosis and NASH relies on liver biopsy. The aim of the study was to identify serum markers of steatosis and NASH in obese patients using SELDI-TOF ProteinChip®.

                  Patients Eighty obese non-alcoholic patient candidates for bariatric surgery and devoid of hepatitis B and C infection were selected. Serum samples were collected before surgery and at 6 months after surgery for 33 of them. Wedge liver biopsy was performed at the time of bariatric surgery. Twenty-four sera of healthy blood donors served as controls. The protein profiles of each serum were assessed using SELDI-TOF ProteinChip technology and were compared according to liver histological lesions.

                  Results Twenty-four obese patients (30%) had non significant liver lesion, 32 (40%) significant steatosis and 24 (30%) NASH. Comparison of serum protein profiles according to liver lesions identified 3 peaks (CM10-7558.4, CM10-7924.2 and Q10-7926.9) the intensity of which significantly increased according to severity of liver lesions (steatosis and NASH) and returned to normal after bariatric surgery. None was correlated with either liver function tests or metabolic parameters. Identification using immunoSELDI assay characterized these peaks as the double charged ions of α\- and β]-hemoglobin subunits.

                  Conclusion Differential Proteomic method demonstrated changes in serum protein profiles in obese patients according to severity of liver lesions. Free hemoglobin subunits may serve as a serum biomarker of severity of liver damages.

                  Statistics from Altmetric.com

                  Request permissions

                  If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

                  Linked Articles

                  • Digest
                    Robin Spiller Magnus Simren